SUBSCRIBE
SUBSCRIBE
News   Business

Johnson & Johnson to Buy $1 Billion Elan Corporation PLC Stake, Work on Alzheimer’s

July 2, 2009 | 
1 min read
Bloomberg -- Johnson & Johnson agreed to pay $1 billion for a stake in Elan Corp. and will develop the Irish drugmaker’s medicines against Alzheimer’s disease.
Alliances Europe
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Illustration showing line of people leaving, standing on top of hand pointing their way out
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
 · 
1 min read
 · 
Angela Gabriel
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cuts at Merck, Disc Leave Hundreds Jobless
March 2, 2026
 · 
60 min read
 · 
BioSpace Editorial Staff
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
 · 
5 min read
 · 
Tristan Manalac
The Westin St. Francis in San Francisco, home of the J.P. Morgan Healthcare Conference.
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
 · 
2 min read
 · 
Annalee Armstrong